Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

(2021) Marcos V. P. Gondim et al.   Science Translational Medicine

Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in people living with HIV with cancer on antiretroviral therapy: The AIDS Malignancy Consortium-095 study

(2021) Thomas A Rasmussen et al.   CLINICAL INFECTIOUS DISEASES

Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response

(2021) Guoxin Wu et al.   JOURNAL OF INFECTIOUS DISEASES

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

(2021) Jennifer M. Zerbato et al.   EBioMedicine

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

(2021) James H. McMahon et al.   EBioMedicine

Considerations for Increasing Racial, Ethnic, Gender and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry

(2021) Karine Dube et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication

(2021) Pablo Tebas et al.   JOURNAL OF CLINICAL INVESTIGATION

High rate of long-term clinical events after ART resumption in HIV-positive patients exposed to antiretroviral therapy interruption

(2021) Valèria Richart et al.   AIDS

Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)

(2021) Jennifer E. Adair et al.   GENE THERAPY

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

(2021) István Tombácz et al.   MOLECULAR THERAPY

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

(2021) Julian D. Gillmore et al.   NEW ENGLAND JOURNAL OF MEDICINE

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

(2021) Devi SenGupta et al.   Science Translational Medicine

Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal

(2021) James H. McMahon et al.   AIDS

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

(2020) Sarah Fidler et al.   LANCET

Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

(2020) Julia Bergild McBrien et al.   NATURE

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

(2020) Christopher C. Nixon et al.   NATURE

Defective HIV-1 proviruses produce viral proteins

(2020) Hiromi Imamichi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections

(2020) Elizabeth M. Anderson et al.   Viruses-Basel

Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity

(2020) Mariya B. Shapiro et al.   Nature Communications

Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment

(2020) Christel Protiere et al.   Journal of the International AIDS Society

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure

(2020) Concepcion Casado et al.   Scientific Reports

Curing HIV: Seeking to Target and Clear Persistent Infection

(2020) David M. Margolis et al.   CELL

BCL-2 antagonism sensitizes cytotoxic T cell–resistant HIV reservoirs to elimination ex vivo

(2020) Yanqin Ren et al.   JOURNAL OF CLINICAL INVESTIGATION

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption

(2020) Julie L. Mitchell et al.   JOURNAL OF CLINICAL INVESTIGATION

Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir

(2020) Pilar Mendoza et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

(2020) Donn J. Colby et al.   NATURE MEDICINE

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

(2020) Beatriz Mothe et al.   Frontiers in Immunology

Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report

(2020) Ravindra Kumar Gupta et al.   Lancet HIV

Everolimus, an mTORC1/2 inhibitor, in ART‐suppressed individuals who received solid organ transplantation: A prospective study.

(2020) Timothy J. Henrich et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Robust Expansion of HIV CAR T Cells Following Antigen Boosting in ART-Suppressed Nonhuman Primates

(2020) Blake J. Rust et al.   BLOOD

Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy

(2020) Shane D Falcinelli et al.   JOURNAL OF INFECTIOUS DISEASES

HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo

(2020) Andrew Timmons et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Extremely low viral reservoir in treated chronically HIV-1-infected individuals

(2020) Cristina Gálvez et al.   EBioMedicine

Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda

(2020) Jessica L. Prodger et al.   JCI Insight

Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults with HIV-1

(2020) Sharon A Riddler et al.   CLINICAL INFECTIOUS DISEASES

Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation

(2020) Yang-Hui Jimmy Yeh et al.   JOURNAL OF CLINICAL INVESTIGATION

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

(2020) Elias K. Halvas et al.   JOURNAL OF CLINICAL INVESTIGATION

SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques is Characterized by Elevated SHIV RNA in the Gut and High Abundance of Intact SHIV DNA in Naïve CD4+ T cells

(2020) Veronica Obregon-Perko et al.   JOURNAL OF VIROLOGY

Distinct viral reservoirs in individuals with spontaneous control of HIV-1

(2020) Chenyang Jiang et al.   NATURE

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

(2020) Mohamed Abdel-Mohsen et al.   NATURE MEDICINE

Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study

(2020) Caroline Passaes et al.   Cell Reports

Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation

(2020) Katherine M. Bricker et al.   PLoS Pathogens

Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir

(2020) Jason Neidleman et al.   eLife

Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial

(2020) Emmanouil Papasavvas et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA

(2020) Christian Gaebler et al.   JOURNAL OF VIROLOGY

The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency

(2020) Luisa Mori et al.   JOURNAL OF VIROLOGY

Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

(2020) Lynn N. Bertagnolli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

(2020) Alessio D. Nahmad et al.   Nature Communications

CRISPR based editing of SIV proviral DNA in ART treated non-human primates

(2020) Pietro Mancuso et al.   Nature Communications

Multi-stakeholder consensus on a target product profile for an HIV cure

(2020) Sharon R Lewin et al.   Lancet HIV

The case for an HIV cure and how to get there

(2020) Mark Dybul et al.   Lancet HIV

Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo

(2020) Francesco R. Simonetti et al.   JOURNAL OF CLINICAL INVESTIGATION

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper

(2020) S. Fidler et al.   Journal of Virus Eradication

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

(2019) Frances H Priddy et al.   Lancet HIV

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

(2019) Boris Julg et al.   Lancet HIV

Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection

(2019) Marion Pardons et al.   PLoS Pathogens

A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation

(2019) Avy Violari et al.   Nature Communications

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

(2019) Ravindra K. Gupta et al.   NATURE

Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression

(2019) José M. Martinez-Navio et al.   IMMUNITY

Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance

(2019) Serena Spudich et al.   JOURNAL OF CLINICAL INVESTIGATION

AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges

(2019) Matthew R. Gardner et al.   Science Translational Medicine

Deep latency: A new insight into a functional HIV cure

(2019) Maher M. Elsheikh et al.   EBioMedicine

HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs

(2019) Marie-Angélique De Scheerder et al.   Cell Host & Microbe

HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

(2019) William R. McManus et al.   JOURNAL OF CLINICAL INVESTIGATION

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure

(2019) Nilu Goonetilleke et al.   Frontiers in Immunology

Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform

(2019) Eytan Herzig et al.   CELL

In Vivo Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses

(2019) Sirish Khanal et al.   JOURNAL OF VIROLOGY

A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses

(2019) Jon M. Steichen et al.   SCIENCE

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

(2019) Melissa-Rose Abrahams et al.   Science Translational Medicine

HIV-1 Latency and Latency Reversal: Does Subtype Matter?

(2019) Indra Sarabia et al.   Viruses-Basel

Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy

(2019) Jenny L Anderson et al.   JOURNAL OF INFECTIOUS DISEASES

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV

(2018) Youry Kim et al.   Cell Host & Microbe

Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4 + T Cells

(2018) Hsiao-Hsuan Kuo et al.   IMMUNITY

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

(2018) Szu-Han Huang et al.   JOURNAL OF CLINICAL INVESTIGATION

SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques

(2018) Maud Mavigner et al.   JOURNAL OF VIROLOGY

HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing

(2018) Steven A. Yukl et al.   Science Translational Medicine

Sex Differences in HIV Infection

(2018) Eileen P. Scully   Current HIV/AIDS Reports

The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies

(2018) Golnaz Namazi et al.   JOURNAL OF INFECTIOUS DISEASES

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

(2018) Pilar Mendoza et al.   NATURE

Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound

(2018) Afam A. Okoye et al.   NATURE MEDICINE

Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir

(2018) Biswajit Das et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant

(2018) Maria Salgado et al.   ANNALS OF INTERNAL MEDICINE

Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation

(2018) Eileen P Scully et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

(2018) Erica N. Borducchi et al.   NATURE

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

(2017) Kersten K. Koelsch et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells

(2017) Guinevere Q. Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

Proliferation of latently infected CD4+T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

(2017) Nina N. Hosmane et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

(2017) Nathan W. Cummins et al.   JOURNAL OF VIROLOGY

Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys

(2017) Nicolas Huot et al.   NATURE MEDICINE

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

(2017) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment

(2017) Cari F. Kessing et al.   Cell Reports

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

(2017) John K. Bui et al.   PLoS Pathogens

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level

(2017) Etienne Canouï et al.   Open Forum Infectious Diseases

Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

(2016) Carolina Gutiérrez et al.   AIDS

The mTOR Complex Controls HIV Latency

(2016) Emilie Besnard et al.   Cell Host & Microbe

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

(2016) Erica N. Borducchi et al.   NATURE

Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity

(2016) Janet Karpinski et al.   NATURE BIOTECHNOLOGY

International AIDS Society global scientific strategy: towards an HIV cure 2016

(2016) Steven G Deeks et al.   NATURE MEDICINE

Defective proviruses rapidly accumulate during acute HIV-1 infection

(2016) Katherine M Bruner et al.   NATURE MEDICINE

Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques

(2016) Ann J Hessell et al.   NATURE MEDICINE

Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy

(2016) Hiromi Imamichi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

(2016) Julio C. C. Lorenzi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clonally expanded CD4+T cells can produce infectious HIV-1 in vivo

(2016) Francesco R. Simonetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

(2016) Rémi Fromentin et al.   PLoS Pathogens

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

(2016) Alison L. Hill et al.   PLoS Pathogens

HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report

(2016) Pierre Frange et al.   Lancet HIV

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

(2016) Steffen Leth et al.   Lancet HIV

Sex, Age, Race and Intervention Type in Clinical Studies of HIV Cure: A Systematic Review

(2015) Rowena E. Johnston et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

HIV-1 Integration Landscape during Latent and Active Infection

(2015) Lillian B. Cohn et al.   CELL

Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations

(2015) Gregory M. Laird et al.   JOURNAL OF CLINICAL INVESTIGATION

Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques

(2015) Philip J Santangelo et al.   NATURE METHODS

Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child

(2015) Katherine Luzuriaga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-treatment control of HIV infection

(2015) Jessica M. Conway et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency

(2015) Guillaume Mousseau et al.   mBio

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing

(2015) Chantelle Ahlenstiel et al.   Molecular Therapy-Nucleic Acids

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

(2015) Julian H Elliott et al.   Lancet HIV

Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus ReactivationIn Vitro

(2014) Christina Gavegnano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

(2014) Pablo Tebas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

(2014) Courtney V. Fletcher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

(2014) A. R. Cillo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

(2014) T. A. Wagner et al.   SCIENCE

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

(2014) F. Maldarelli et al.   SCIENCE

Natural history of HIV-control since seroconversion

(2013) Yoann Madec et al.   AIDS

Effect of Antiretroviral Therapy on HIV Reservoirs in Elite Controllers

(2013) Tae-Wook Chun et al.   JOURNAL OF INFECTIOUS DISEASES

Immune clearance of highly pathogenic SIV infection

(2013) Scott G. Hansen et al.   NATURE

Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

(2013) Deborah Persaud et al.   NEW ENGLAND JOURNAL OF MEDICINE

17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription

(2013) Erika L. Szotek et al.   VIROLOGY

Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

(2013) Susanne Eriksson et al.   PLoS Pathogens

Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

(2013) Steven A. Yukl et al.   PLoS Pathogens

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

(2013) Asier Sáez-Cirión et al.   PLoS Pathogens

Comprehensive analysis of unique cases with extraordinary control over HIV replication

(2012) D. Mendoza et al.   BLOOD

Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIVAD8in Rhesus Macaques: Implications for Use in Vaccine Studies

(2012) Rajeev Gautam et al.   JOURNAL OF VIROLOGY

HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency

(2011) Torsten Schaller et al.   PLoS Pathogens

Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene Expression

(2010) Abhyudai Singh et al.   BIOPHYSICAL JOURNAL

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

(2009) Nicolas Chomont et al.   NATURE MEDICINE

Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation

(2009) Gero Hütter et al.   NEW ENGLAND JOURNAL OF MEDICINE